Drug Makers Join Efforts in Research Ten of the world’s largest pharmaceutical companies said on Wednesday that they would cooperate on research aimed at acceler
FDA, IMI, and Patient Advocates to Present at CDISC 2012 International Interchange Formal Launch of CFAST – Collaboration between C-Path and CDISC The Clinical Data Interchange Standards Consortium (CDISC) and Critical Path Institute (C-Path) announce the launch of the Coaliti
C-Path, CDISC launch “breakthrough” tool for TB drug development A “breakthrough” tool that standardises reporting of research data in the development of drug regimens to combat tuber
August 28, 2012 Towards Consensus Development: Qualifying Endpoint Measures for Rheumatoid Arthritis Clinical Trails August 28, 2012 Sheraton Silver Spring Hotel 8777 Georgia Avenue – Silver Spring, MD 20910 SPONSORED BY: Critical Path Insti
Science foundation invaluable to Arizona The inclusion of C-Path in the Star’s centennial “100 Days of Science” series is a most welcome honor. What need
Race against a million deaths begins at Tucson’s C-Path When I’ll Have Another won the Kentucky Derby in May, no one talked about the hundreds of millions of dollars each year that
Revisiting the multiple sclerosis functional composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures
Approval of new drugs slowing Fewer new prescription drugs will get approved in the U.S. this year than the 30 approved in 2011, a ratings agency forecasts, add
Tucson tech: Tucson’s C-Path drug institute looks to boost its future funding Tucson’s Critical Path Institute recently got some good news – and some noteworthy recognition – when the U.S. S
CDISC, C-Path and FDA Collaborate to Develop Data Standards to Streamline Path to New Therapies The Clinical Data Interchange Standards Consortium (CDISC) and the Critical Path Institute (C-Path) announce the signing of a part